Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

NCT01714817 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

695

Enrollment

INDUSTRY

Sponsor class

Stopped Inability to meet protocol objectives.

Conditions

Lupus Nephritis

Interventions

BIOLOGICAL: BMS-188667
DRUG: Mycophenolate mofetil
DRUG: Prednisone
BIOLOGICAL: Placebo matching with BMS-188667

Sponsor

Bristol-Myers Squibb